Clinical Trials in Arizona

Showing 13741-13760 of 16,770 trials

A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

NCT01362231

The study consists of 2 parts: Part A is a randomized, multiple-dose, double-blind, placebo-controlled sequential dose escalation study to evaluate GS-6624 in subjects with Idiopathic Pulmonary Fibrosis (IPF) and was completed in October 2011. Part B is a randomized, two-dose, open-label dose expansion study to evaluate GS-6624 in subjects with IPF and is currently enrolling.

Idiopathic Pulmonary Fibrosis

Gilead Sciences48 participantsStarted Dec 2010

Scottsdale, Arizona, United States • Los Angeles, California, United States • Stanford, California, United States +4 more locations

COMPLETEDPhase 131 miles

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

NCT00413322

This is a study to assess the combination of PXD101 and 5-Fluorouracil (5-FU)in patients with advanced solid tumors. The primary goal of the study is to understand the safety, anti-tumor activity, and how the study drug behaves within the body when given with 5-Fluorouracil (5-FU).

Tumor

Valerio Therapeutics35 participantsStarted Sep 2005

Scottsdale, Arizona, United States • Omaha, Nebraska, United States • Portsmouth, New Hampshire, United States

A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Find Trials by Condition in Arizona

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

Rollover Study of VX-770 in Cystic Fibrosis Subjects

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

MANAGE Automated Glucose Monitoring